Lithium is a naturally occurring element that, at therapeutic doses, alters brain chemistry, kidney function, thyroid activity, and metabolism. It remains one of the most effective treatments for bipolar disorder, but its effects reach well beyond mood stabilization. Because the body doesn’t break lithium down the way it processes most drugs, the kidneys handle nearly all of its elimination, and even small shifts in blood concentration can change how it affects you.
How Lithium Changes Brain Chemistry
Lithium works on several neurotransmitter systems at once, which is part of why it’s effective for such a complex condition and part of why its full mechanism still isn’t completely mapped. Its influence on dopamine is one of the clearest: lithium reduces excessive dopamine activity, which is thought to be a key reason it controls manic episodes. In animal studies, chronic lithium treatment restored abnormal dopamine release in the brain’s reward center back to normal levels.
Lithium also enhances serotonin signaling, primarily by acting on the sending side of the nerve connection. Brain imaging studies in people with bipolar depression have shown that patients with lower baseline serotonin activity experienced greater improvement after starting lithium, suggesting the drug compensates for serotonin deficits. There’s also evidence linking lithium’s effectiveness to genes involved in the glutamate system, which handles excitatory signaling between neurons.
Beyond neurotransmitters, lithium blocks an enzyme called GSK-3 beta that, when overactive, contributes to inflammation, oxidative stress, and nerve cell death. By inhibiting this enzyme, lithium triggers a cascade that increases a protein called BDNF, which is essential for neuron survival, growth, and repair. This is why long-term lithium use has been associated with preserved or even increased gray matter volume in the brain, a finding that sets it apart from most psychiatric medications.
What It Does to Your Kidneys
The kidneys are lithium’s only exit route from the body. Unlike most medications, lithium isn’t processed by the liver at all. Renal clearance averages about 24 milliliters per minute, and the drug’s half-life ranges from roughly 19 to 41 hours, meaning it takes five to six days of consistent dosing to reach a stable blood level.
One of lithium’s most common effects is making the kidneys less responsive to the hormone that tells them to conserve water. Lithium interferes with the collecting ducts, reducing the production of a signaling molecule those cells need to respond to antidiuretic hormone. It also decreases the expression of water channels (called aquaporin-2) in kidney cells. The result is that your kidneys let more water pass through than they should, causing increased urination and thirst. Early on, this is reversible. Over years, it can progress to structural changes in kidney tissue that are harder to undo.
Effects on the Thyroid and Parathyroid
Lithium concentrates in the thyroid gland and can slow its hormone production. Thyroid dysfunction is one of the three main endocrine side effects of lithium treatment, alongside elevated calcium levels and the kidney-related water balance issues described above. People on lithium typically get their thyroid levels checked regularly, and some eventually need thyroid hormone supplementation.
The parathyroid glands, which regulate calcium, are also affected. In one study of 112 people with bipolar disorder taking lithium, 8.6% developed overactive parathyroid function and 24.1% developed elevated calcium levels. A larger Swedish study found parathyroid overactivity in up to 18% of long-term lithium users. High calcium can cause fatigue, bone thinning, kidney stones, and cognitive fog, so calcium and parathyroid hormone levels are monitored alongside lithium blood draws.
Common Side Effects and Their Timeline
The side effects most people notice first are thirst, frequent urination, nausea, diarrhea, and a fine hand tremor. Nausea affects 10 to 20% of people starting lithium and tends to fade substantially after the first weeks of treatment. Tremor also typically appears early but can emerge at any point. In some cases, it improves on its own after years of use.
Weight gain is a frequently cited concern, though the reality is more nuanced than its reputation suggests. About one-third of lithium users experience meaningful weight gain. However, in controlled studies, the numbers are modest. One 12-week trial found lithium users gained an average of just 0.2 kilograms, and a year-long study showed a gain of 1.1 kilograms, which wasn’t significantly different from placebo. People who were not already overweight before starting lithium showed almost no weight gain compared to placebo. The weight effect also appears to be dose-related: modern practice uses lower blood levels (0.6 to 0.8 mmol/L) than the higher ranges used in previous decades, which likely reduces this side effect.
The Narrow Therapeutic Window
Lithium has one of the narrowest therapeutic ranges of any commonly prescribed medication. For long-term maintenance in bipolar disorder, the recommended blood level is 0.60 to 0.80 mmol/L. This can be lowered to 0.40 to 0.60 mmol/L if someone responds well but tolerates the drug poorly, or raised to 0.80 to 1.00 mmol/L if the response is insufficient. There is no evidence that going above 1.00 mmol/L provides additional benefit for maintenance, though acute manic episodes sometimes call for levels near the top of that range.
The gap between a therapeutic level and a toxic one is small. Mild toxicity begins at 1.5 mEq/L and causes nausea, vomiting, lethargy, tremor, and fatigue. Moderate toxicity, at 2.5 to 3.5 mEq/L, brings confusion, agitation, delirium, rapid heart rate, and muscle rigidity. Severe toxicity above 3.5 mEq/L can cause seizures, coma, dangerously low blood pressure, and overheating. This is why regular blood monitoring is a non-negotiable part of lithium treatment.
Medications That Shift Lithium Levels
Because the kidneys handle all of lithium’s elimination, anything that changes kidney function can push lithium levels up or down. Three common medication classes are the biggest culprits.
- Thiazide diuretics (often prescribed for high blood pressure) increase lithium concentrations by 25 to 40% after starting therapy, making them the most significant interacting drug class.
- NSAIDs like ibuprofen and naproxen have also been linked to lithium toxicity, though the degree of interaction varies between specific drugs.
- ACE inhibitors (another common blood pressure medication) appear to impair lithium elimination, though the risk is harder to predict on an individual basis.
Dehydration from illness, exercise, or hot weather also reduces kidney clearance of lithium and can tip someone from a safe level into a toxic one. This is why people on lithium are advised to maintain consistent fluid and salt intake.
Neuroprotective Properties
One of the more striking findings about lithium is that it does more than manage symptoms. By blocking the GSK-3 beta enzyme, lithium activates a signaling chain that reduces inflammation in nerve tissue, protects against oxidative damage, and prevents the kind of protein tangles associated with neurodegeneration. Animal research has shown that lithium can reverse cognitive deficits and depression-like behavior caused by chemotherapy drugs, specifically by restoring the growth-factor signaling that keeps neurons healthy and connected.
These neuroprotective effects have sparked interest in lithium’s potential role beyond psychiatry, particularly in neurodegenerative conditions where nerve cell loss is the central problem. Even at the low end of therapeutic dosing, lithium appears to preserve brain tissue in ways that other mood stabilizers do not.